Dear Friends and Colleagues,

GLP-1 receptor agonists are rapidly reshaping modern medicine—redefining standards of care in diabetes, obesity, MASH, and PCOS. Now, emerging evidence suggests these powerful therapies may also transform how we understand and manage chronic inflammatory skin diseases, particularly through their impact on metabolic dysfunction and systemic inflammation.

As clinicians, we are increasingly confronted with patients whose inflammatory skin conditions are closely intertwined with obesity and metabolic syndrome—yet a dedicated forum addressing this critical multi-organ interplay has been missing.

To meet this need, we are delighted to invite you to a high-impact, one-day scientific meeting focused exclusively on this evolving field:

GLP-1 and Inflammatory Skin Diseases
Wednesday, July 15, 2026
The New York Academy of Medicine

Organized by the team behind the biennial Inflammatory Skin Disease Summit, which recently welcomed over 850 international participants to New York City, this meeting will bring together leading experts to deliver cutting-edge science, clinical insights, and practical takeaways you can apply immediately to patient care.

If you want to stay at the forefront of innovation—where metabolism, immunology, and dermatology converge—this is a meeting you won’t want to miss.

We look forward to welcoming you to New York for an inspiring and practice-changing day of education.

Warm regards,

The Organizing Committee